Treatment of hepatitis C virus infection: Updated Swedish Consensus recommendations-Reference-Cited by-同舟云学术

Treatment of hepatitis C virus infection: Updated Swedish Consensus recommendations

Published:2009-01 Issue:6-7 Volume:41 Page:389-402
ISSN:0036-5548
Container-title:Scandinavian Journal of Infectious Diseases
language:en
Short-container-title:Scandinavian Journal of Infectious Diseases

Author:

Lagging Martin,Wejstål Rune,Uhnoo Ingrid,Gerdén Barbro,Fischler Björn,Friman Styrbjörn,Josephson Filip,Karlström Olle,Sangfelt Per,Schvarz Robert,Weiland Ola,For The Swedish Consensus Group ,Lagging Martin,Wejstål Rune,Uhnoo Ingrid,Gerdén Barbro,Fischler Björn,Friman Styrbjörn,Josephson Filip,Karlström Olle,Sangfelt Per,Schvarz Robert,Weiland Ola,For The Swedish Consensus Group

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/00365540902998271

Reference75 articles.

1. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C

2. Risk of Non-Hodgkin Lymphoma and Lymphoproliferative Precursor Diseases in US Veterans With Hepatitis C Virus

3. Hepatitis C virus-related lymphoproliferative disorders: An overview

4. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance1 1The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in hepatitis C virus prevalence and incidence among people who inject drugs in the direct acting antiviral era;International Journal of Drug Policy;2024-06

2. Persistence of hepatitis B surface antibody to hepatitis B vaccine among medical college students in Najran University, Saudi Arabia;Bioinformation;2022-07-31

3. Peg-IFN and ribavirin treatment for recurrence of genotype 2 and 3 hepatitis C after liver transplantation;Infectious Diseases;2015-02-04

4. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies;Scandinavian Journal of Gastroenterology;2014-12-17

5. Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment;Brazilian Journal of Pharmaceutical Sciences;2014-04